Skip to main content

Table 7 Serum FST levels in patients with LADC according to N category

From: Association of serum follistatin levels with histological types and progression of tumor in human lung cancer

 

n

Mean ± SD, pg/mL

Minimum–maximum, pg/mL

Healthy subjects

37

760.09 ± 115.65

570.88–1170.24

Benign diseases

22

1225.60 ± 323.40#

608.36–1763.76

LADC

33

  

 N0

17

1375.80 ± 214.15#

877.29–1763.76

 N1

2

1525.10 ± 102.28

1422.81–1627.38

 N2

12

1672.84 ± 329.78#**S

1150.05–2241.09

 N3

2

1934.24 ± 34.09

1900.14–1968.33

  1. #P < 0.01 compared with the healthy group; * P < 0.05, ** P < 0.01, compared with benign disease group
  2. SP < 0.05 compared with group N0